vs
ARROWHEAD PHARMACEUTICALS, INC.（ARWR）与Essex Property Trust（ESS）财务数据对比。点击上方公司名可切换其他公司
Essex Property Trust的季度营收约是ARROWHEAD PHARMACEUTICALS, INC.的1.8倍（$479.6M vs $264.0M），Essex Property Trust净利率更高（17.9% vs 11.7%，领先6.2%），ARROWHEAD PHARMACEUTICALS, INC.同比增速更快（10461.3% vs 5.5%）
Arrowhead Pharmaceuticals是总部位于美国加利福尼亚州帕萨迪纳的上市生物制药企业，专注于通过RNA干扰（RNAi）作用机制开发创新药物，核心研发管线覆盖乙型肝炎、α-1抗胰蛋白酶缺陷相关肝病及心血管疾病的治疗领域。
Essex Property Trust是一家公开上市的房地产投资信托企业，重点布局美国西海岸优质不动产市场，核心投资标的为加利福尼亚州及西雅图大都会区的公寓类物业，在长租公寓的投资、运营及管理领域拥有深厚的行业积累与资源优势。
ARWR vs ESS — 直观对比
营收规模更大
ESS
是对方的1.8倍
$264.0M
营收增速更快
ARWR
高出10455.8%
5.5%
净利率更高
ESS
高出6.2%
11.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $264.0M | $479.6M |
| 净利润 | $30.8M | $85.7M |
| 毛利率 | — | 70.0% |
| 营业利润率 | 15.5% | 31.7% |
| 净利率 | 11.7% | 17.9% |
| 营收同比 | 10461.3% | 5.5% |
| 净利润同比 | 117.8% | -71.6% |
| 每股收益（稀释后） | $0.22 | $1.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARWRESS
| Q4 25 | $264.0M | $479.6M | ||
| Q3 25 | — | $473.3M | ||
| Q2 25 | — | $469.8M | ||
| Q1 25 | — | $464.6M | ||
| Q4 24 | — | $454.5M | ||
| Q3 24 | — | $450.7M | ||
| Q2 24 | — | $442.4M | ||
| Q1 24 | — | $426.9M |
净利润ARWRESS
| Q4 25 | $30.8M | $85.7M | ||
| Q3 25 | — | $172.7M | ||
| Q2 25 | — | $231.5M | ||
| Q1 25 | — | $212.8M | ||
| Q4 24 | — | $301.7M | ||
| Q3 24 | — | $125.5M | ||
| Q2 24 | — | $99.0M | ||
| Q1 24 | — | $285.1M |
毛利率ARWRESS
| Q4 25 | — | 70.0% | ||
| Q3 25 | — | 69.2% | ||
| Q2 25 | — | 70.7% | ||
| Q1 25 | — | 69.6% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 69.5% | ||
| Q2 24 | — | 70.8% | ||
| Q1 24 | — | 69.7% |
营业利润率ARWRESS
| Q4 25 | 15.5% | 31.7% | ||
| Q3 25 | — | 44.5% | ||
| Q2 25 | — | 59.5% | ||
| Q1 25 | — | 55.3% | ||
| Q4 24 | — | 67.0% | ||
| Q3 24 | — | 28.6% | ||
| Q2 24 | — | 31.1% | ||
| Q1 24 | — | 31.0% |
净利率ARWRESS
| Q4 25 | 11.7% | 17.9% | ||
| Q3 25 | — | 36.5% | ||
| Q2 25 | — | 49.3% | ||
| Q1 25 | — | 45.8% | ||
| Q4 24 | — | 66.4% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 22.4% | ||
| Q1 24 | — | 66.8% |
每股收益（稀释后）ARWRESS
| Q4 25 | $0.22 | $1.24 | ||
| Q3 25 | — | $2.56 | ||
| Q2 25 | — | $3.44 | ||
| Q1 25 | — | $3.16 | ||
| Q4 24 | — | $4.00 | ||
| Q3 24 | — | $1.84 | ||
| Q2 24 | — | $1.45 | ||
| Q1 24 | — | $4.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $715.0M | $76.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $568.4M | $5.5B |
| 总资产 | $1.6B | $13.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ARWRESS
| Q4 25 | $715.0M | $76.2M | ||
| Q3 25 | — | $66.0M | ||
| Q2 25 | — | $58.7M | ||
| Q1 25 | — | $98.7M | ||
| Q4 24 | — | $66.8M | ||
| Q3 24 | — | $71.3M | ||
| Q2 24 | — | $55.2M | ||
| Q1 24 | — | $499.0M |
总债务ARWRESS
| Q4 25 | — | — | ||
| Q3 25 | — | $6.4B | ||
| Q2 25 | — | $6.4B | ||
| Q1 25 | — | $6.8B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $6.4B | ||
| Q2 24 | — | $6.2B | ||
| Q1 24 | — | $6.6B |
股东权益ARWRESS
| Q4 25 | $568.4M | $5.5B | ||
| Q3 25 | — | $5.6B | ||
| Q2 25 | — | $5.6B | ||
| Q1 25 | — | $5.6B | ||
| Q4 24 | — | $5.5B | ||
| Q3 24 | — | $5.4B | ||
| Q2 24 | — | $5.5B | ||
| Q1 24 | — | $5.5B |
总资产ARWRESS
| Q4 25 | $1.6B | $13.2B | ||
| Q3 25 | — | $13.2B | ||
| Q2 25 | — | $13.2B | ||
| Q1 25 | — | $13.2B | ||
| Q4 24 | — | $12.9B | ||
| Q3 24 | — | $12.6B | ||
| Q2 24 | — | $12.5B | ||
| Q1 24 | — | $12.9B |
负债/权益比ARWRESS
| Q4 25 | — | — | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.22× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.18× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 1.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.5M | $1.1B |
| 自由现金流经营现金流 - 资本支出 | $11.3M | — |
| 自由现金流率自由现金流/营收 | 4.3% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | 0.44× | 12.53× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ARWRESS
| Q4 25 | $13.5M | $1.1B | ||
| Q3 25 | — | $342.6M | ||
| Q2 25 | — | $216.1M | ||
| Q1 25 | — | $281.5M | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $316.2M | ||
| Q2 24 | — | $218.9M | ||
| Q1 24 | — | $314.9M |
自由现金流ARWRESS
| Q4 25 | $11.3M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ARWRESS
| Q4 25 | 4.3% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ARWRESS
| Q4 25 | 0.8% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ARWRESS
| Q4 25 | 0.44× | 12.53× | ||
| Q3 25 | — | 1.98× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 1.32× | ||
| Q4 24 | — | 3.54× | ||
| Q3 24 | — | 2.52× | ||
| Q2 24 | — | 2.21× | ||
| Q1 24 | — | 1.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
